Chesapeake IRB Announces Acquisition of Institutional Biosafety Corporation

08:00 EDT 6 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Chesapeake IRB, the leading technology-enabled independent institutional review board (IRB) serving the clinical research industry, announced it has acquired Institutional Biosafety Corporation (IBC), a provider of instit...

Other Sources for this Article

For Chesapeake IRB:
Lea Studer, 308-237-5567
SCORR Marketing


More From BioPortfolio on "Chesapeake IRB Announces Acquisition of Institutional Biosafety Corporation"

Quick Search


Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...